2m 2m 2m 2m 2m 2m 2m
ADC Therapeutic N (ADCT)
NYSE
$1.00-$0.002 (-0.16%)
Price as of Aug 21, 2026 7:30 PM EDT- $129.3MMarket Cap
- -68.66%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ADC Therapeutic N (ADCT)
$1.00-$0.002 (-0.16%)
ADCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.00 | ||
Change | +$0.04 (+3.80%) | ||
Open | $0.97 | ||
High | $1.00 | ||
Low | $0.97 | ||
Previous Close | $0.96 | ||
Volume | 1,088,237 | ||
30-Day Average Volume | 1,242,799 | ||
1-Week Change | -1.33% | ||
1-Month Change | -21.53% | ||
1-Year Change | -68.66% | ||
3-Year Change | -27.26% | ||
5-Year Change | -96.05% | ||
Fundamentals | |||
Shares Outstanding | 129.7M | ||
Total Assets | $279.4M | ||
Market Cap | $129.3M | ||
Enterprise Value | $26.8M | ||
Period: QTR TTM FY | |||
Revenue | $19.2M | ||
Net Income | -$16.6M | ||
Free Cash Flow | -$11.8M | ||
EBIT | -$12.2M | ||
EBITDA | -$12.2M | ||
Net Working Capital | $175.4M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 1 | ||
P/B | -1 | ||
P/E | -9 | ||
PEG | -0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 05/10/2005 | ||
Earnings & Revenue